Paid Clinical Trials Murfreesboro

Discover 833 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 833

PovorcitinibA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Murfreesboro TN, Birmingham AL, Clarksville IN, Anderson SCshow 36 more

Code:

NCT06516952

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

SonelokimabStudy to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared with Placebo in Adult Participants with Moderate to Severe Hidradenitis Suppurativa

Recruiting

PHASE3

Sponsor:

MoonLake Immunotherapeutics AG

Location:

Murfreesboro TN, Murray KY, Birmingham AL, Plainfield INshow 32 more

Code:

NCT06411379

Conditions

Hidradenitis Suppurativa

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sonelokimab

Placebo

Observational StudyC-Brace Prospective Registry

Recruiting

Sponsor:

Otto Bock Healthcare Products GmbH

Location:

Murfreesboro TN, Danville KY, Evansville IN, Buford GAshow 47 more

Code:

NCT04640584

Conditions

Pareses

Lower Extremity

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

C-Brace

Sleep QualityEnhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

Recruiting

Sponsor:

University of Alabama, Tuscaloosa

Location:

Murfreesboro TN, San Marcos TX, Lakewood CO

Code:

NCT05820919

Conditions

Alzheimer Disease

Dementia

Sleep Disorder

Sleep Disturbance

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

LOCK Sleep Program

No intervention (control period/baseline data collection)

Ruxolitinib CreamA Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Murfreesboro TN, Marietta GA, Columbus GA, Little Rock ARshow 23 more

Code:

NCT06238817

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ruxolitinib Cream

Vehicle Cream

DazodalibepA Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Recruiting

PHASE3

Sponsor:

Amgen

Location:

Murfreesboro TN, Jackson TN, Miamisburg OH, Augusta GAshow 38 more

Code:

NCT06104124

Conditions

Sjogren's Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dazodalibep

Placebo

VDPHL01Efficacy and Safety of VDPHL01 in Males with AGA

Recruiting

PHASE2

PHASE3

Sponsor:

Veradermics, Inc.

Location:

Murfreesboro TN, Nashville TN, Knoxville TN, Birmingham ALshow 40 more

Code:

NCT06724614

Conditions

Androgenetic Alopecia

AGA

Male Pattern Baldness

Eligibility Criteria

Sex: Male

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

VDPHL01

Placebo

Dapirolizumab PegolA Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Recruiting

PHASE3

Sponsor:

UCB Biopharma SRL

Location:

Murfreesboro TN, Jackson TN, Marietta GA, Gainesville GAshow 23 more

Code:

NCT06617325

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

DZP

Placebo

Ruxolitinib CreamA Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Recruiting

PHASE1

Sponsor:

Incyte Corporation

Location:

Murfreesboro TN, Bowling Green KY, Columbus GA, Indianapolis INshow 17 more

Code:

NCT06213831

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Ruxolitinib Cream 1.5%

EltrekibartA Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Murfreesboro TN, Nashville TN, Bowling Green KY, Louisville KYshow 40 more

Code:

NCT06046729

Conditions

Hidradenitis Suppurativa

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Eltrekibart

Placebo